Related Experiment Video
Updated: Oct 4, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor beta receptor signaling and endocytosis are linked through a COOH terminal activation
N Garamszegi1, J J Doré, S G Penheiter
1Thoracic Diseases Research Unit, Mayo Clinic, Rochester, MN 55905, USA.
Abstract:
Transforming growth factor beta (TGF-beta) coordinates a number of biological events important in normal and pathophysiological growth. In this study, deletion and substitution mutations were used to identify receptor motifs modulating TGF-beta receptor activity. Initial experiments indicated that a COOH-terminal sequence between amino acids 482-491 in the kinase domain of the type I receptor was required for ligand-induced receptor signaling and down-regulation. These 10 amino acids are highly conserved in mammalian, Xenopus, and Drosophila type I receptors. Although mutation or deletion of the region (referred to as the NANDOR BOX, for nonactivating non-down-regulating) abolishes TGF-beta-dependent mitogenesis, transcriptional activity, type I receptor phosphorylation, and down-regulation in mesenchymal cultures, adjacent mutations also within the kinase domain are without effect. Moreover, a kinase-defective type I receptor can functionally complement a mutant BOX expressing type I receptor, documenting that when the BOX mutant is activated, it has kinase activity. These results indicate that the sequence between 482 and 491 in the type I receptor provides a critical function regulating activation of the TGF-beta receptor complex.
Insights
A specific region in the TGF-beta type I receptor, the NANDOR BOX, is essential for signaling and receptor regulation. Mutations here block TGF-beta-driven cell growth and activity.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Transforming growth factor beta (TGF-beta) is a key regulator of cellular processes, including growth and development.
- Dysregulation of TGF-beta signaling is implicated in various pathological conditions.
Purpose of the Study:
- To identify specific receptor motifs that modulate TGF-beta receptor activity.
- To elucidate the role of a conserved sequence in the type I receptor's kinase domain.
Main Methods:
- Utilized deletion and substitution mutations in the type I TGF-beta receptor.
- Assessed the impact of mutations on ligand-induced signaling, receptor phosphorylation, and down-regulation.
- Performed functional complementation assays with a kinase-defective receptor.
Main Results:
- A COOH-terminal sequence (amino acids 482-491), termed the NANDOR BOX, is critical for TGF-beta receptor signaling and down-regulation.
- Mutations or deletions within the NANDOR BOX abolished TGF-beta-dependent mitogenesis, transcriptional activity, and receptor phosphorylation.
- Adjacent mutations within the kinase domain did not affect receptor function.
- A kinase-defective receptor could complement a NANDOR BOX mutant, indicating the BOX regulates activation.
Conclusions:
- The NANDOR BOX sequence is indispensable for regulating TGF-beta receptor activation.
- This conserved motif plays a critical role in mediating TGF-beta's biological effects.
- Understanding this regulatory mechanism offers insights into TGF-beta-related diseases.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
07:05TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade
Amplifying Signals via Second Messengers
Enzyme-linked Receptors